ORIC

5.67

1.80% 0.10

Dopo l'orario di chiusura: 5.68 0.010 +0.18%

Oric Pharmaceuticals Inc (ORIC)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Precedente Chiudi:

$5.57

Aprire:

$5.64

Volume 24 ore:

482.62K

Relative Volume:

0.47

Capitalizzazione di mercato:

$362.53M

Reddito:

Utile/perdita netta:

$-119.87M

Rapporto P/E:

-3.1326

EPS:

-1.81

Flusso di cassa netto:

$-109.90M

1 W Prestazione:

+11.18%

1M Prestazione:

-1.90%

6M Prestazione:

-39.74%

1 anno Prestazione:

-40.44%

Intervallo 1D:

$5.44

$5.83

Intervallo di 1 settimana:

$5.00

$5.90

Portata 52W:

$3.8951

$14.67

Oric Pharmaceuticals Inc Stock (ORIC) Company Profile

Nome

Oric Pharmaceuticals Inc

Settore

Healthcare (1152)

Industria

Biotechnology (677)

Telefono

(650) 388-5600

Indirizzo

240 E. GRAND AVE., SOUTH SAN FRANCISCO, CA

Dipendente

115

Cinguettio

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

ORIC's Discussions on Twitter

Confronta ORIC con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
ORIC Oric Pharmaceuticals Inc	5.67	362.53M	0	-119.87M	-109.90M	-1.81
VRTX Vertex Pharmaceuticals Inc	501.15	126.96B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	605.61	65.06B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	649.67	37.54B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	259.39	32.56B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	255.77	26.40B	3.81B	-644.79M	-669.77M	-6.24

Oric Pharmaceuticals Inc Stock (ORIC) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-10-31	Iniziato	Wells Fargo	Overweight
2024-09-06	Iniziato	Stifel	Buy
2024-02-23	Iniziato	Cantor Fitzgerald	Overweight
2023-09-22	Iniziato	Wedbush	Outperform
2023-03-23	Aggiornamento	H.C. Wainwright	Neutral → Buy
2023-03-21	Aggiornamento	Guggenheim	Neutral → Buy
2023-03-16	Aggiornamento	Oppenheimer	Perform → Outperform
2022-07-18	Ripresa	Oppenheimer	Perform
2022-04-04	Aggiornamento	Citigroup	Neutral → Buy
2022-03-25	Downgrade	H.C. Wainwright	Buy → Neutral
2022-03-22	Downgrade	Citigroup	Buy → Neutral
2022-03-22	Downgrade	Guggenheim	Buy → Neutral
2022-03-22	Downgrade	Oppenheimer	Outperform → Perform
2021-07-06	Aggiornamento	Citigroup	Neutral → Buy
2021-01-25	Downgrade	Citigroup	Buy → Neutral
2020-08-13	Iniziato	Robert W. Baird	Outperform
2020-08-06	Aggiornamento	Citigroup	Neutral → Buy
2020-08-03	Iniziato	H.C. Wainwright	Buy
2020-05-19	Iniziato	Citigroup	Neutral
2020-05-19	Iniziato	Guggenheim	Buy
2020-05-19	Iniziato	JP Morgan	Overweight
2020-05-19	Iniziato	Jefferies	Buy

Mostra tutto

Oric Pharmaceuticals Inc Borsa (ORIC) Ultime notizie

04:48 AM

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) | ORIC Stock News - GuruFocus

04:48 AM

04:43 AM

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

04:43 AM

04:30 AM

Oncology Biotech ORIC Issues Major Equity Package: 32,400 Options Plus RSUs for New Talent - Stock Titan

04:30 AM

09:55 AM

An analyst sees good growth prospects for ORIC Pharmaceuticals Inc (ORIC) - Sete News

09:55 AM

07:40 AM

Market Watch: ORIC Pharmaceuticals Inc (ORIC)’s Noteworthy Drop, Closing at 5.57 - DWinneX

07:40 AM

04:55 AM

Adage Capital Partners GP L.L.C. Has $4.04 Million Stake in ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) - MarketBeat

04:55 AM

02:22 AM

ORIC Pharmaceuticals (ORIC) Expected to Announce Earnings on Monday - MarketBeat

02:22 AM

May 01, 2025

Is ORIC Pharmaceuticals Inc (ORIC) worth investing in despite its overvalued state? - uspostnews.com

May 01, 2025

ORIC Pharmaceuticals, Inc. (NASDAQ:ORIC) Shares Sold by Legal & General Group Plc - Defense World

May 01, 2025

Apr 30, 2025

ORIC Pharmaceuticals Inc’s Shares Reel: -51.58% Quarterly Revenue Decline Amid 401.98M Market Cap - investchronicle.com

Apr 30, 2025